Detalhe da pesquisa
1.
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
Blood
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484137
2.
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
Blood
; 140(25): 2697-2708, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700381
3.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668287
4.
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Br J Haematol
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797530
5.
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
Clin Hematol Int
; 6(2): 11-20, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817307